How to Validate a Simulated Yogurt-Choice Study
On this page
A yogurt brand considering a functional product needs to understand how product type, brand familiarity, price and a health claim affect stated choice. A simulation can explore that question, but a published human study validates only its own task. A useful replication must show which estimates match, which miss and whether the comparison applies to the proposed launch.
What does the human reference establish?
The human reference is Ares and colleagues' study of functional versus regular yogurts. Its choice-based conjoint task combines yogurt type, brand, price and the presence or absence of a reduced-disease-risk claim. Product types include regular yogurt and versions enriched with antioxidants or fibre; brand levels distinguish national or foreign origin and familiarity.
Those attributes describe a choice task, not clinical evidence that a yogurt reduces disease risk. Before reusing the task, recover its sample, exact wording, levels and analysis. A change in the claim, brand familiarity or price can change the experiment.
A study-specific replication score requires a dated run record that makes the simulated and human estimates comparable. This page reports no yogurt-specific replication score because no dated public run record exists. The aggregate working paper does not supply one.
What should a yogurt team check before using the estimates?
| Check | Evidence to inspect | Why it changes the decision |
|---|---|---|
| Product type | Same descriptions of regular and enriched products | Adding a benefit changes what consumers evaluate |
| Brand familiarity | Matched definitions and relevant customer population | Familiarity in the original sample may not transfer to a new market |
| Price | Original levels, currency and coding | Similar preference ranks do not establish demand at a launch price |
| Claim | Identical wording and presentation | A different implied benefit tests a different message |
| Estimate comparison | Same reference levels, parameter definitions and uncertainty | An agreement score is useful only when the estimates are comparable |
Record model configuration, run date, repeated runs and possible exposure to the original paper. A published task may be present in training data, so agreement alone cannot establish performance on an unseen product. Report disagreements and missing estimates alongside a score.
What does the public aggregate benchmark show?
Subconscious's July 2026 causal-fidelity working paper, not peer reviewed, reports mean Spearman rank correlation on estimated choice parameters of 0.55 across roughly 300 replications and 0.73 across the 43 studies passing design filters. Those are aggregate results for a different reporting scope. They do not supply a missing yogurt-study score, an accuracy percentage or evidence of realized purchasing lift.
How does the study change a launch decision?
For a new fibre-enriched yogurt, first decide whether the question is product preference, price acceptance or the effect of a particular message. Use alternatives that isolate the intended comparison. Treat modeled choice as evidence about that task, then require a human or market check appropriate to the launch risk.
A message experiment also cannot establish the truth of a health benefit. The FTC's health-products guidance calls for substantiation appropriate to the claim. A team considering disease-risk language needs that evidence and suitable professional review before publication, regardless of whether the message performs well in a choice task.
The commercial recommendation should therefore identify the tested population, the exact product and message, uncertainty in the estimates and the next validation step. A historical replication is useful context; a launch still needs evidence for its own customers and outcome.
Review the public methodology for the aggregate measurement task. Book a decision review to scope the alternatives, target population and validation needed for a yogurt-category decision.